These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17551688)

  • 1. Systematic reviews highlight the complex balance between good and harm from screening studies.
    Moja L; Moschetti I; Liberati A; Gensini GF; Gusinu R
    Intern Emerg Med; 2007 Mar; 2(1):57-9. PubMed ID: 17551688
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screening.
    Mandrik O; Zielonke N; Meheus F; Severens JLH; Guha N; Herrero Acosta R; Murillo R
    Int J Cancer; 2019 Aug; 145(4):994-1006. PubMed ID: 30762235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The breast cancer screening debate: closing a chapter?
    Lancet; 2012 Nov; 380(9855):1714. PubMed ID: 23117179
    [No Abstract]   [Full Text] [Related]  

  • 4. What determines the effects and costs of breast cancer screening? A protocol of a systematic review of reviews.
    Mandrik O; Ekwunife OI; Zielonke N; Meheus F; Severens JL; Lhachimi SK; Murillo R
    Syst Rev; 2017 Jun; 6(1):122. PubMed ID: 28659183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The truth in reviews.
    van der Meer JW
    Neth J Med; 2002 Jun; 60(5):191. PubMed ID: 12365473
    [No Abstract]   [Full Text] [Related]  

  • 6. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests.
    Deeks JJ
    BMJ; 2001 Jul; 323(7305):157-62. PubMed ID: 11463691
    [No Abstract]   [Full Text] [Related]  

  • 7. Systematic reviews as a "lens of evidence": Determinants of participation in breast cancer screening.
    Mandrik O; Tolma E; Zielonke N; Meheus F; Ordóñez-Reyes C; Severens JL; Murillo R
    J Med Screen; 2021 Jun; 28(2):70-79. PubMed ID: 32517538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible net harms of breast cancer screening: updated modelling of Forrest report.
    Raftery J; Chorozoglou M
    BMJ; 2011 Dec; 343():d7627. PubMed ID: 22155336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arab women's breast cancer screening practices: a literature review.
    Donnelly TT; Khater AH; Al-Bader SB; Al Kuwari MG; Al-Meer N; Malik M; Singh R; Jong FC
    Asian Pac J Cancer Prev; 2013; 14(8):4519-28. PubMed ID: 24083695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for prostate cancer: protocol for updating multiple systematic reviews to inform a Canadian Task Force on Preventive Health Care guideline update.
    Bennett A; Beck A; Shaver N; Grad R; LeBlanc A; Limburg H; Gray C; Abou-Setta A; Klarenbach S; Persaud N; Thériault G; Thombs BD; Todd KJ; Bell N; Dahm P; Loblaw A; Del Giudice L; Yao X; Skidmore B; Rolland-Harris E; Brouwers M; Little J; Moher D
    Syst Rev; 2022 Oct; 11(1):230. PubMed ID: 36289518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochrane review on screening for breast cancer with mammography.
    Olsen O; Gøtzsche PC
    Lancet; 2001 Oct; 358(9290):1340-2. PubMed ID: 11684218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mammography screening. More harm than good?].
    Wettig D
    MMW Fortschr Med; 2011 Jan; 153(4):22. PubMed ID: 22165612
    [No Abstract]   [Full Text] [Related]  

  • 13. The benefits and harms of screening for cancer with a focus on breast screening.
    Brodersen J; Jørgensen KJ; Gøtzsche PC
    Pol Arch Med Wewn; 2010 Mar; 120(3):89-94. PubMed ID: 20332715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for breast cancer with mammography.
    Duffy SW; Tabar L; Smith RA
    Lancet; 2001 Dec 22-29; 358(9299):2166; author reply 2167-8. PubMed ID: 11784655
    [No Abstract]   [Full Text] [Related]  

  • 15. Systematic reviews as a "lens of evidence": Determinants of cost-effectiveness of breast cancer screening.
    Mandrik O; Ekwunife OI; Meheus F; Severens JLH; Lhachimi S; Uyl-de Groot CA; Murillo R
    Cancer Med; 2019 Dec; 8(18):7846-7858. PubMed ID: 31568702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Office of NHS cancer screening programme misrepresents Nordic work in breast screening row.
    Gøtzsche PC
    BMJ; 2001 Nov; 323(7321):1131. PubMed ID: 11701587
    [No Abstract]   [Full Text] [Related]  

  • 17. [Breast cancer: dangers of alleged certainties].
    Junod B; Massé R; Quélier C
    Sante Publique; 2004 Mar; 16(1):21-6. PubMed ID: 15185582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Population screening for breast cancer: between euphoria and scepticism].
    Bossuyt PM
    Ned Tijdschr Geneeskd; 2002 Jun; 146(22):1020-3. PubMed ID: 12073501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit and harm associated with screening for breast cancer.
    Sox HC
    N Engl J Med; 1998 Apr; 338(16):1145-6. PubMed ID: 9545364
    [No Abstract]   [Full Text] [Related]  

  • 20. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
    van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
    Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.